These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8127052)

  • 1. Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype.
    Hopwood JJ; Vellodi A; Scott HS; Morris CP; Litjens T; Clements PR; Brooks DA; Cooper A; Wraith JE
    J Inherit Metab Dis; 1993; 16(6):1024-33. PubMed ID: 8127052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A common mutation for mucopolysaccharidosis type I associated with a severe Hurler syndrome phenotype.
    Scott HS; Litjens T; Hopwood JJ; Morris CP
    Hum Mutat; 1992; 1(2):103-8. PubMed ID: 1301196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-L-iduronidase mutations (Q70X and P533R) associate with a severe Hurler phenotype.
    Scott HS; Litjens T; Nelson PV; Brooks DA; Hopwood JJ; Morris CP
    Hum Mutat; 1992; 1(4):333-9. PubMed ID: 1301941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bone marrow transplantation in mucopolysaccharidosis type I, Hurler-Scheie variety. Metabolic correction and clinical results].
    Ortega Aramburu JJ; Domínguez Luengo C; Olivé Oliveras T; Navarro Fernández C
    An Esp Pediatr; 1990 Oct; 33(4):369-75. PubMed ID: 2126172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
    Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA
    J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation for feline mucopolysaccharidosis I.
    Ellinwood NM; Colle MA; Weil MA; Casal ML; Vite CH; Wiemelt S; Hasson CW; O'Malley TM; He X; Prociuk U; Verot L; Melniczek JR; Lannon A; Aguirre GD; Knox VW; Evans SM; Vanier MT; Schuchman EH; Walkley SU; Haskins ME
    Mol Genet Metab; 2007 Jul; 91(3):239-50. PubMed ID: 17482862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hurler disease (mucopolysaccharidosis type IH): clinical features and consanguinity in Tunisian population.
    Chkioua L; Khedhiri S; Ben Turkia H; Chahed H; Ferchichi S; Ben Dridi MF; Laradi S; Miled A
    Diagn Pathol; 2011 Nov; 6():113. PubMed ID: 22074387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I.
    Pievani A; Azario I; Antolini L; Shimada T; Patel P; Remoli C; Rambaldi B; Valsecchi MG; Riminucci M; Biondi A; Tomatsu S; Serafini M
    Blood; 2015 Mar; 125(10):1662-71. PubMed ID: 25298037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-I.
    Kuehn SC; Koehne T; Cornils K; Markmann S; Riedel C; Pestka JM; Schweizer M; Baldauf C; Yorgan TA; Krause M; Keller J; Neven M; Breyer S; Stuecker R; Muschol N; Busse B; Braulke T; Fehse B; Amling M; Schinke T
    Hum Mol Genet; 2015 Dec; 24(24):7075-86. PubMed ID: 26427607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplant in a case of mucopolysaccharidosis I Scheie phenotype: skin ultrastructure before and after transplantation.
    Navarro C; Dominguez C; Costa M; Ortega JJ
    Acta Neuropathol; 1991; 82(1):33-8. PubMed ID: 1950476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy in a patient with mucopolysaccharidosis type IH homozygous for the W402X mutation.
    Hendriksz CJ; Moss GM; Wraith JE
    J Inherit Metab Dis; 2004; 27(5):685-6. PubMed ID: 15669685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of mucopolysaccharidosis type I: mutation analysis among the patients of the former Soviet Union.
    Voskoboeva EY; Krasnopolskaya XD; Mirenburg TV; Weber B; Hopwood JJ
    Mol Genet Metab; 1998 Oct; 65(2):174-80. PubMed ID: 9787109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased longevity and metabolic correction following syngeneic BMT in a murine model of mucopolysaccharidosis type I.
    Wolf DA; Lenander AW; Nan Z; Braunlin EA; Podetz-Pedersen KM; Whitley CB; Gupta P; Low WC; McIvor RS
    Bone Marrow Transplant; 2012 Sep; 47(9):1235-40. PubMed ID: 22179554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations among Italian mucopolysaccharidosis type I patients.
    Gatti R; DiNatale P; Villani GR; Filocamo M; Muller V; Guo XH; Nelson PV; Scott HS; Hopwood JJ
    J Inherit Metab Dis; 1997 Nov; 20(6):803-6. PubMed ID: 9427149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation analysis of 19 North American mucopolysaccharidosis type I patients: identification of two additional frequent mutations.
    Clarke LA; Nelson PV; Warrington CL; Morris CP; Hopwood JJ; Scott HS
    Hum Mutat; 1994; 3(3):275-82. PubMed ID: 8019563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic mutations and the relationship with clinical phenotype in patients with mucopolysaccharidosis type I in northeast Mexico].
    Sánchez Suárez AL; Sánchez Sánchez LM
    Gac Med Mex; 2014; 150(4):289-96. PubMed ID: 25098213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications.
    Scott HS; Bunge S; Gal A; Clarke LA; Morris CP; Hopwood JJ
    Hum Mutat; 1995; 6(4):288-302. PubMed ID: 8680403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 12 year follow up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment.
    Gabrielli O; Clarke LA; Ficcadenti A; Santoro L; Zampini L; Volpi N; Coppa GV
    BMC Med Genet; 2016 Mar; 17():19. PubMed ID: 26965916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease.
    Lutzko C; Omori F; Abrams-Ogg AC; Shull R; Li L; Lau K; Ruedy C; Nanji S; Gartley C; Dobson H; Foster R; Kruth S; Dubé ID
    Hum Gene Ther; 1999 Jun; 10(9):1521-32. PubMed ID: 10395377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.